The study aims to evaluate the effectiveness of intravenous immunoglobulin (IVIG) for treating Alzheimer's disease (AD) based on animal experiments.
Conducted a systematic review of animal experiments related to IVIG and AD.
Analyzed various studies focusing on the functional properties of IVIG.
Synthesis included qualitative assessments without meta-analysis.
IVIG's efficacy on Alzheimer's disease remains unresolved.
Findings indicate that effects are closely tied to the specific functional properties of IVIG.
Abstract
Intravenous immunoglobulin (IVIG)'s efficacy on Alzheimer's disease (AD) remains inconclusive and appears closely related to specific functional properties.